Mutational Analysis of Stress-responsive Peanut Dual Specificity Protein Kinase

IDENTIFICATION OF TYROSINE RESIDUES INVOLVED IN REGULATION OF PROTEIN KINASE ACTIVITY*

Parvathi Rudrabhatla and Ram RajasekharanDagger

From the Department of Biochemistry, Indian Institute of Science, Bangalore 560012, India

Received for publication, January 2, 2003, and in revised form, February 27, 2003

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We recently reported that Arachis hypogaea serine/threonine/tyrosine (STY) protein kinase is developmentally regulated and is induced by abiotic stresses (Rudrabhatla, P., and Rajasekharan, R. (2002) Plant Physiol. 130, 380-390). Other than MAPKs, the site of tyrosine phosphorylation has not been documented for any plant kinases. To study the role of tyrosines in the phosphorylation of STY protein kinase, four conserved tyrosine residues were sequentially substituted with phenylalanine and expressed as histidine fusion proteins. Mass spectrometry experiments showed that STY protein kinase autophosphorylated within the predicted kinase ATP-binding motif, activation loop, and an additional site in the C terminus. The protein kinase activity was abolished by substitution of Tyr297 with Phe in the activation loop between subdomains VII and VIII. In addition, replacing Tyr148 in the ATP-binding motif and Tyr317 in the C-terminal domain with Phe not only obliterated the ability of the STY protein kinase protein to be phosphorylated, but also inhibited histone phosphorylation, suggesting that STY protein kinase is phosphorylated at multiple sites. Replacing Tyr213 in the Thr-Glu-Tyr sequence motif with Phe resulted in a 4-fold increase in autophosphorylation and 2.8-fold increase in substrate phosphorylation activities. Mutants Y148F, Y297F, and Y317F displayed dramatically lower phosphorylation efficiency (kcat/Km) with ATP and histone, whereas mutant Y213F showed increased phosphorylation. Our results suggest that autophosphorylation of Tyr148, Tyr213, Tyr297, and Tyr317 is important for the regulation of STY protein kinase activity. Our study reveals the first example of Thr-Glu-Tyr domain-mediated autoinhibition of kinases.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Tyrosine phosphorylation plays an important role in the regulation of many cellular processes. The activity of the enzymes governing this modification, protein-tyrosine kinases and phosphatases, needs to be tightly controlled for tyrosine phosphorylation to proceed in an orderly manner. Improper phosphorylation due to malfunction of protein-tyrosine kinases and phosphatases can lead to diseases in humans and animals, including immunodeficiencies and cancer (1). In higher plants, several serine/threonine kinases have been identified, but the presence of protein-tyrosine kinases remains controversial. No tyrosine kinase has hitherto been cloned from plants. However, tyrosine phosphorylation in plants has been shown to be involved in various physiological processes (2-4). Dual specificity protein kinases have been reported in Arabidopsis (5, 6) and soybean (7), but the functions for these kinases remain unknown. We recently reported that serine/threonine/tyrosine (STY)1 protein kinase from Arachis hypogaea is developmentally regulated and induced by abiotic stress (8). The site of tyrosine phosphorylation has not been identified for any dual specificity protein kinases in plants. However, MAPKs have been shown to be activated by dual phosphorylation of threonine and tyrosine in the Thr-Glu-Tyr (TEY) motif in the activation loop (9). Recently, the role of threonines in the phosphorylation of receptor-like kinase has been identified in plants (10, 11).

Most protein kinases retain their kinase domain conserved sequence motifs, which are separated into subdomains I-XI. The region between the conserved DFG sequence motif in subdomain VII and the APE sequence motif in subdomain VIII is referred to as the activation loop. Several protein kinases such as cAMP-dependent protein kinase (12), a MAPK family (13), a MAPK kinase (MEK) family (14, 15), a cyclin-dependent protein kinase family (16), and c-Src tyrosine kinase (17) are activated by phosphorylation of residues within the activation loop (18). Phosphorylation negatively regulates a substantial number of protein kinases. For example, phosphorylation of cyclin-dependent protein kinase at threonine and tyrosine residues in the ATP-binding loop by wee1-related kinases leads to kinase inactivation (16), and phosphorylation of the Src tyrosine kinase at a tyrosine residue in the C terminus maintains the kinase in an inactive conformation (18).

Here we report a novel site of autoinhibition of STY protein kinase. In contrast to the above-mentioned kinases, we demonstrate here that the phosphorylation of Tyr148 in the ATP-binding domain and of Tyr317 in the C-terminal domain activates STY protein kinase. The replacement of Tyr297 with Phe in the activation loop resulted in a drastic reduction in the phosphorylation of peanut STY protein kinase with ATP and histone. This study provides direct evidence for the tyrosine phosphorylation of peanut STY protein kinase.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Histone H1 (type IIIS), monoclonal anti-phosphotyrosine antibody, phosphoamino acids, and calf intestinal alkaline phosphatase were purchased from Sigma. [gamma -32P]ATP (3000 Ci/mmol) was obtained from PerkinElmer Life Sciences. Restriction endonucleases were from MBI Fermentas (St. Leon-Rot, Germany). Pfu polymerase was from New England Biolabs Inc. (Beverly, MA). Nickel-nitrilotriacetic acid-agarose was obtained from QIAGEN Inc. (Chatsworth, CA). Oligonucleotides were synthesized by Microsynth (Balgach, Switzerland).

Bacterial Strains, Growth Conditions, and DNA Manipulations-- Escherichia coli strain DH5alpha (Invitrogen) was the recipient for all plasmids used in subcloning. The BL21(DE3) pLysS strain (19) was used for bacterial expression of pRSET-C-STY and its protein kinase tyrosine mutants. LB medium with 50 µg/ml ampicillin was used for growing E. coli cells containing the plasmids. Plasmids were prepared by the alkaline lysis method (20). The DNA fragments were eluted from the agarose gel by the low melting agarose gel method. The preparation of competent cells and transformation were carried out as described (20).

Matrix-assisted Laser Desorption Ionization (MALDI) Mass Spectrometry-- Two micrograms of STY protein kinase or autophosphorylated STY protein kinase was electrophoresed on SDS-polyacrylamide gel and visualized by Coomassie Blue staining. STY protein kinase bands were then excised from the gel, transferred to an acid-washed tube, rehydrated with water, crushed, washed three times for 20 min with 50 mM Tris-HCl (pH 8.0) and 50% acetonitrile, and dried. The sample was incubated for 6 h at 32 °C with 0.80 ng/ml trypsin in 25 mM Tris-HCl (pH 8.5) to digest the protein. The tryptic fragments were then extracted with 50% acetonitrile and 0.1% trifluoroacetic acid; dried; suspended in 10 mg/ml 4-hydroxy-alpha -cyanocinnamic acid in 50% acetonitrile and 0.1% trifluoroacetic acid containing angiotensin as an internal standard; and applied to a MALDI sample plate, which was dried and washed with water to remove excess buffer salts. MALDI mass spectrometry analysis was performed on a Kratos PCKompact Seq 1.2.2 mass spectrometer in the linear mode. The masses obtained in these experiments were searched against predicted tryptic fragments of STY protein kinase using the program PeptideMass (21).

Site-directed Mutagenesis-- Wild-type STY protein kinase (pRSET-C-STY) template (80 ng) and sense and antisense primers (25 pmol) were added to PCR tubes containing 0.2 mM dNTPs, 1 mM MgSO4, 2.5 units of Pfu polymerase, and 1× reaction buffer. Amplification was carried out under the following conditions: denaturation of the template at 95 °C for 4 min, followed by 20 cycles at 94 °C for 45 s (denaturation), 52 °C for 1 min (annealing), and 72 °C for 9 min (extension). The reaction was continued for 20 min at 72 °C to complete the extension. The primers for K160R (sense, 5'-ATAATGGTGAGGATGTAGCTA-3'; and antisense, 5'-TAGCTACATCCTCACCATTAT-3'), Y148F (sense, 5'-GGAAAACTCTTTAGGGGAACTT-3'; and antisense, 5'-AAGTTCCCCTAAAGAGTTTTCC-3'), Y213F (sense, 5'-GTAACGGAATTTGCCAAAGGG-3'; and antisense, 5'-CCCTTTGGCAAATTCCGTTAC-3'), Y297F (sense, 5'-ACTGGAACATTCCGTTGGATG-3'; and antisense, 5'-CATCCAACGGAATGTTCCAGT-3'), and Y317F (sense, 5'-GGTGGATGTGTTTAGCTTTGGG-3'; and antisense, 5'-CCCAAAGCTAAACACATCCACC-3') were used on recombinant pRSET-C-STY protein kinase to construct site-directed mutants. The PCR-amplified mixture was treated with DpnI (10 units) at 37 °C for 1 h to digest the methylated template and transformed into DH5alpha competent cells. The presence of mutations was confirmed by sequencing the plasmid DNA.

Expression and Purification of Wild-type STY Protein Kinase and Its Mutants-- The cDNA spanning the coding region of STY protein kinase (lacking 11 amino acids from the N terminus) was subcloned into the histidine-tagged fusion protein expression vector pRSET-C at BglI and KpnI restriction sites. The resultant construct was expressed in E. coli BL21(DE3) pLysS. The recombinant fusion protein was induced with 0.4 mM isopropyl-1-thio-beta -D-galactopyranoside for 4 h. The recombinant protein was induced in large-scale (500 ml) and purified by nickel-nitrilotriacetic acid-agarose chromatography. Protein concentrations were determined by the method of Bradford (22). Purified fractions containing the eluted protein were analyzed by 12% SDS-PAGE, followed by Coomassie Blue staining (23). Mutant proteins were purified similarly to wild-type STY protein kinase.

Assay of Tyrosine Phosphorylation-- Samples of the His6-tagged STY protein kinase and mutant fusion proteins were separated on 12% SDS-polyacrylamide gel, transferred onto a nitrocellulose membrane, and probed with monoclonal anti-phosphotyrosine antibody.

In Vitro Kinase Assay-- ATP dependence assays were performed by incubating the STY protein kinase and mutant fusion proteins (1 µg) with 0.1-500 µM ATP containing 1.5 µCi of [gamma -32P]ATP in a total volume of 20 µl of kinase buffer and stopped at 20 min by the addition of 10 µl of 3× gel loading buffer. Histone phosphorylation assays were performed by incubating the STY protein kinase and mutant fusion proteins with 2.5-40 µM histone H1 containing 50 µM unlabeled ATP and 1.5 µCi of [gamma -32P]ATP in a total volume of 30 µl of kinase buffer and stopped at 20 min by the addition of 15 µl of 3× gel loading buffer. The reaction products were separated by 12% SDS-PAGE. The Coomassie Blue-stained protein bands were recovered and then measured using a beta -scintillation counter. Km and Vmax values were estimated according to the double-reciprocal plot and linear regression using SigmaPlot 2000 Version 6 software (SPSS Inc., Chicago, IL).

Phosphoamino Acid Analysis-- Purified STY protein kinase and the mutant proteins were labeled in vitro with [gamma -32P]ATP as described above and electroblotted onto a polyvinylidene difluoride membrane. After autoradiography, radioactive bands of interest were excised and hydrolyzed in 200 µl of 6 M HCl for 2 h at 110 °C. The hydrolysate was dried in a SpeedVac concentrator and resuspended in 20 µl of water containing 1 mg/ml each of the phosphoamino acid markers such as phosphoserine, phosphothreonine, and phosphotyrosine. Two microliters of the hydrolysate was analyzed by ascending silica thin-layer chromatography (Merck) using a solvent system containing a mixture of ethanol and ammonia (3.5:1.6, v/v) (24). The positions of phosphoamino acid markers were detected by ninhydrin staining of the silica thin-layer plate (0.25% ninhydrin in acetone). The plate was then exposed for autoradiography to locate the positions of the 32P-labeled amino acids.

Calf Intestinal Alkaline Phosphatase Treatment of the Recombinant Kinase-- The histidine fusion protein of STY protein kinase was incubated with 1 unit of calf intestinal alkaline phosphatase for 30 min at 37 °C, and the phosphorylated and dephosphorylated kinases were resolved by 15% SDS-PAGE.

Circular Dichroism-- CD studies were performed using a Jasco J-720 spectropolarimeter with a thermostatically controlled 10-mm cylindrical CD cell at 4 µM protein. For near-UV and UV-visible wavelengths, protein concentrations ranged from 0.8 to 1 mg/ml using a 1-cm path length. The CD spectra are the averages of five independent experiments on different samples of the same enzyme preparation recorded at a scan speed of 50 nm/min with a bandwidth of 2 nm and averaged automatically. All spectra were corrected for the appropriate blank solutions, recorded in the absence of enzyme. The values are expressed in terms of molar ellipticity.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Sequence Comparison of the STY Protein Kinase Activation Loop with Tyrosine Kinases and Dual Specificity Protein Kinases Regulated by Tyrosine Phosphorylation-- A schematic representation of the STY protein kinase catalytic domain with all 11 subdomains representing the site-directed mutations generated in this study is shown in Fig. 1A. STY protein kinase has four conserved tyrosine residues that are present in the ATP-binding domain (subdomain I), the TEY sequence motif (subdomain V), the activation loop (subdomain VIII), and toward the C terminus (subdomain IX). Short sequences between the conserved DFG motif in subdomain VII and the APE sequence motif in subdomain VIII of the protein kinase domains are referred to as the activation loop. STY protein kinase contains a single tyrosine (Tyr297) in the activation loop (Fig. 1B). The site of tyrosine phosphorylation has not been identified in plant kinases. Therefore, we compared STY protein kinase with the dual specificity protein kinases from all the species (Fig. 1B). The protein sequence of STY protein kinase has homology to the DYRK family of kinases from mammals, and DYRK is an intracellular dual specificity protein kinase that is regulated by tyrosine phosphorylation of the activation loop (25). Based on the assumption that the kinase activity of STY protein kinase may be regulated by the phosphorylation of the tyrosine residue in the activation loop, we constructed an STY protein kinase mutant with Tyr297 replaced with Phe by site-directed mutagenesis. Alignment of Src tyrosine kinases and STY protein kinase revealed the presence of a conserved tyrosine in the TEY motif subdomain V (Fig. 1C). To elucidate the role of Tyr213 in the TEY motif, site-directed substitution of tyrosine with phenylalanine was performed.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic representation of the STY protein kinase catalytic domain and identification of site-directed mutations. A, the locations of Tyr148, Lys160, Tyr213, Tyr297, and Tyr317 of STY protein kinase mutated in this study. B, sequence comparison of protein kinases that are regulated by phosphorylation of the presumed activation loop between domains VII and VIII. The conserved DFG sequence in subdomain VII and the APE sequence in subdomain VIII are boxed. Asterisks above tyrosine residues indicate activating phosphorylation sites. The GenBankTM/EBI Data Bank accession numbers are as follows: STY protein kinase (A. hypogaea), AY037437; ATN1 (Arabidopsis thaliana), S61766; DYRK (Drosophila melanogaster), P83102; and DYRK (Homo sapiens), NP_006473. C, sequence alignment of subdomain V of STY protein kinase with Src tyrosine kinase from chicken (Protein Data Bank code 2PTK) and human (code 2SRC) and with c-ABL kinase from mice (code 1IEPA). The TEY motif in subdomain V is boxed. D, locations of STY protein kinase autophosphorylation sites (indicated by red circles on the molecule backbone) in the predicted secondary structure. N and C indicate the N and C termini of the structure, respectively. Green arrows indicate boundaries of the STY protein kinase activation loop, which lies between Asp277 and Glu303. alpha -Helices and beta -strands are colored in magenta and yellow, respectively.

Homology Modeling-- The x-ray structures of the mouse c-ABL kinase domain in complex with the inhibitor STI-571 (Protein Data Bank code 1IEPA), human protein-tyrosine kinase (code 2SRC), and chicken protein-tyrosine kinase (code 2PTK) were used as templates for modeling the STY protein kinase catalytic domain. These templates produced the best E value when using BLAST against protein kinase in the Protein Data Bank. A three-dimensional model of the catalytic domain of STY protein kinase was determined using SWISS-MODEL (26) and visualized by RasMol (27). The consensus tyrosine kinase motif CWX6RPXF in subdomain XI is conserved among the proteins. STY protein kinase has the consensus IVTEY motif that is conserved in Src family kinases in subdomain V. The predicted STY protein kinase molecule resembles the typical structure of a protein kinase catalytic domain, consisting of a small lobe, which is involved in ATP binding and orientation, and a large lobe, which provides sites for substrate recognition and catalysis (28). The small lobe represents the N terminus of the molecule and consists predominantly of beta -strands, whereas the large lobe represents the C terminus of the molecule and includes several alpha -helices. STY protein kinase autophosphorylation sites are scattered throughout the kinase catalytic domain (Fig. 1D). The activation loop helix that spans between Asp277 and Glu303 packs between the N-terminal and C-terminal lobes and sequesters Tyr297.

Phosphorylation Site Mapping by MALDI Time-of-Flight Mass Spectrometry Analysis-- We carried out mass spectrometry experiments to identify autophosphorylation sites. Recombinant STY protein kinase was digested with trypsin before and after an extended autophosphorylation reaction, and the protein was analyzed by MALDI mass spectrometry (Fig. 2). Phosphorylation increased the peptide mass by 80 Da. Tryptic fragments of STY protein kinase that were found in the unphosphorylated state and those that were shifted by the mass of a phosphate (+80 Da) in the autophosphorylated samples were studied. One of the major peaks (2541.20 Da) fitting these criteria (peak b) has a mass that corresponds to a peptide from the activation loop of STY protein kinase. This tryptic peptide contains a single tyrosine (Tyr297). Two other peaks (peaks a and c) correspond to Tyr148 (450 Da) in the ATP-binding domain and Tyr317 (3850.02 Da) in subdomain IX, respectively. Corresponding unphosphorylated peptides were not detected in the MALDI time-of-flight mass spectra of the autophosphorylated kinase. We did not observe any evidence for phosphorylation of Tyr213 in the TEY motif in STY protein kinase (Fig. 2). These results suggest the possibility of STY protein kinase being phosphorylated at multiple sites and that Tyr148, Tyr297, and Tyr317 are the autophosphorylation sites.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 2.   Identification of STY protein kinase autophosphorylation sites by MALDI mass spectrometry. Recombinant kinase or autophosphorylated STY protein kinase (2 µg) was subjected to 12% SDS-PAGE and visualized by Coomassie Blue staining. The STY protein kinase bands were excised from the gel and subjected to in-gel trypsin digestion. Tryptic fragments of native STY protein kinase (A) and autophosphorylated STY protein kinase (B) were analyzed by MALDI mass spectrometry. Peaks a-c are STY protein kinase peptides that were present in their unphosphorylated state in the native sample, and peaks a'-c' are STY protein kinase peptides that were present in their phosphorylated state (+80 Da) in the autophosphorylated sample. There was no change in the phosphorylation of the tryptic peptide shown by peak d. The tryptic peptide masses and phosphorylation sites are summarized at the bottom. Insets show the MALDI time-of-flight mass spectra of tryptic peptides up to 1000 Da.

Expression and Purification of Wild-type STY Protein Kinase and Substituted STY Protein Kinase Mutants-- Based on the comparative sequence analysis, homology modeling, and phosphopeptide mapping, the conserved Tyr148, Tyr213, Tyr297, and Tyr317 residues of STY protein kinase were substituted with Phe by site-directed mutagenesis. All the mutant proteins were overproduced in E. coli BL21(DE3) pLysS using the T7 RNA polymerase expression system, induced by isopropyl-thio-beta -D-galactoside, and purified by nickel-nitrilotriacetic acid affinity chromatography. The expressed proteins were predominantly present in the soluble fraction, and yields of the proteins were in the range of 10-15 mg/liter. The expression levels of and the ability to purify the STY protein kinase mutants suggested that they were as stable as the wild-type protein.

Tyrosine Phosphorylation of STY Protein Kinase Mutants-- To determine the degree of autophosphorylation, equal quantities of histidine fusion proteins of the wild-type and mutant STY protein kinases were subjected to anti-phosphotyrosine and anti-STY protein kinase immunoblot analyses. Notably, there was a significant increase in the reactivity of the anti-phosphotyrosine antibody with the Y213F mutant protein (Fig. 3A). The tyrosine mutations at positions 148, 297, and 317 diminished the reactivity of STY protein kinase with the anti-phosphotyrosine antibody. When the same blot was subjected to anti-STY protein kinase Western blot analysis, there was no difference in the reactivities of the wild-type and mutant proteins (Fig. 3B). There was a slight downshift in the mobility of the Y148F, Y297F, and Y317F mutant proteins with respect to the wild-type protein. When wild-type STY protein kinase was subjected to phosphatase treatment, we observed faster mobility of the protein upon SDS-PAGE compared with the untreated protein (Fig. 3C). The downshift in mobility of the protein kinase inactive mutants could be due to the phosphorylation status of the protein.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   Tyrosine phosphorylation of the STY protein kinase mutants in which the autophosphorylated tyrosines were replaced with phenylalanines. A, affinity-purified histidine fusion proteins of wild-type (WT) STY protein kinase and its mutants were run on 12% SDS-polyacrylamide gel, transferred onto a nitrocellulose membrane, and subjected to anti-phosphotyrosine (Anti-pY) immunoblot analysis. B, shown is an anti-STY protein kinase immunoblot illustrating equal loading of the fusion proteins. C, shown is the dephosphorylation of wild-type STY protein kinase with calf intestinal alkaline phosphatase (CIAP). Lane 1, 15% SDS-polyacrylamide gel representing molecular mass standards; lane 2, wild-type STY protein kinase; lane 3, calf intestinal alkaline phosphatase-treated STY protein kinase.

Effect of Tyrosine Mutations on Kinase Activity-- The kinase activities of all the site-directed mutants were assessed by comparing their abilities to autophosphorylate and phosphorylate histone in vitro (Fig. 4). As a negative control, the conserved lysine in subdomain II involved in ATP binding was changed to arginine to form a kinase inactive mutant (K160R), and the mutant did not show autophosphorylation or substrate phosphorylation. Preincubation of STY protein kinase and the site-directed mutants with magnesium and unlabeled ATP resulted in a reduced level of labeled phosphate incorporation (Fig. 4, A and B). Replacement of Tyr213 with Phe resulted in a 4-fold increase in autophosphorylation and a 2.8-fold increase in histone phosphorylation. Elevated tyrosine phosphorylation of the Y213F mutant protein was accompanied by reduced mobility upon SDS-PAGE. We analyzed the relative incorporation of 32P label into the phosphoamino acids. Surprisingly, the Y213F mutant showed an increased band intensity of phosphoserine, phosphothreonine, and phosphotyrosine with respect to the wild-type protein, suggesting that serines, threonines, and tyrosines were phosphorylated (Fig. 5). Substitution of Tyr148 in the ATP-binding domain with Phe decreased both autophosphorylation and substrate phosphorylation. There is a single tyrosine (Tyr297) in the activation loop upstream of the APE sequence in STY protein kinase, and its replacement with phenylalanine strongly decreased both autophosphorylation and substrate phosphorylation. The site-specific mutation of Y317F in the C-terminal motif also resulted in a drastic reduction in protein kinase activity (Fig. 4, A-D). Phosphoamino acid analyses of the Y148F, Y297F, and Y317F mutant proteins revealed a drastic reduction in phosphorylation of tyrosine with respect to the wild-type protein (Fig. 5). These results suggest that the mutated sites could play a role in the regulation of STY protein kinase.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Autophosphorylation and histone phosphorylation of STY protein kinase and its mutants. Bacterially produced STY protein kinase and its mutants were purified, and 500 ng of protein was incubated with [gamma -32P]ATP to determine kinase activity. After separation by 12% SDS-PAGE, the resulting gels were analyzed using a PhosphorImager. A, autoradiographs of autophosphorylation of wild-type (WT) STY protein kinase and mutants Y148F, Y213F, Y297F, and Y317F. As indicated, the proteins were preincubated with or without 0.5 mM unlabeled ATP in the same buffer for 30 min. B, histogram constructed with data from A. Black bars, autophosphorylated enzymes without preincubation with ATP; white bars, autophosphorylated enzymes preincubated with ATP. The error bars represent the S.D. of three independent experiments. C, histone phosphorylation of wild-type and site-directed mutants. Aliquots of 500 ng of purified STY protein kinase and its mutants were incubated with 1 µg of histone in the presence of [gamma -32P]ATP as described under "Experimental Procedures." After separation by 12% SDS-PAGE, the resulting gels were analyzed using a PhosphorImager. Shown are autoradiographs of histone incubated with wild-type STY protein kinase, K160R, Y148F, Y213F, Y297F, and Y317F. D, histogram constructed with data from C. The error bars represent the S.D. of four experiments.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5.   Phosphoamino acid analyses of the STY protein kinase mutants in which the autophosphorylated tyrosines were replaced with phenylalanines. A, phosphoamino acid analysis of autophosphorylated STY protein kinase and the site-directed mutants. Recombinant STY protein kinase and the site-directed mutants (1 µg) were autophosphorylated, resolved by 12% SDS-PAGE, and transferred onto a polyvinylidene difluoride membrane. The reaction products were hydrolyzed and separated by silica thin-layer chromatography as described under "Experimental Procedures." The positions of the origin (ori), phosphoserine (PS), phosphothreonine (PT), and phosphotyrosine (PY) are indicated. WT, wild-type STY protein kinase, B, histogram constructed with data from A. The error bars represent the S.D. of four experiments.

Kinetics of Autophosphorylation of STY Protein Kinase Mutants-- STY protein kinase exhibited Michaelis-Menten kinetics with respect to ATP. The apparent Km value for ATP was calculated to be 34.4 µM (Table I). The Y213F mutant showed an increase in phosphorylation activity with respect to the wild-type protein; hence, we investigated whether the kinetic properties of this mutant deviated significantly from that of the wild-type enzyme. The mutation decreased the apparent Km from 34.4 to 18.8 µM and increased the kcat value (Table I). The phosphorylation efficiency of this mutant (kcat/Km) was 5-fold higher than that of the wild-type enzyme.


                              
View this table:
[in this window]
[in a new window]
 
Table I
Kinetic constants of wild-type STY protein kinase and its mutants

The same analyses were performed with mutants Y148F, Y297F, and Y317F (Table I). There was a significant reduction in the affinity of the Y148F mutant for ATP, and the Km of the mutant increased by 3-fold and the kcat was reduced by 5-fold compared with those of the wild-type enzyme. A drastic reduction (17-fold) in the phosphorylation efficiency of this mutant was observed compared with that of the wild-type protein. The Y297F mutant also showed a 26-fold reduction in phosphorylation efficiency compared with the wild-type enzyme. The Km of the Y317F mutant deviated slightly from that of the wild-type protein, but the kcat and phosphorylation efficiency of this mutant protein were drastically reduced by 20- and 38-fold, respectively, compared with those of the wild-type protein. These results suggest that the tyrosine mutations reported in this study significantly altered the phosphorylation activity.

Kinetics of Histone Phosphorylation of STY Kinase Mutants-- The wild-type enzyme has an apparent Km of 6.71 µM (Table I). The Y213F mutation showed no apparent effect on the Km, but led to an increase (2-fold) in the kcat. The Y148F mutant was substantially less active than the wild-type enzyme, with 5-fold lower phosphorylation efficiency and a 1.6-fold higher Km for histone. A decrease in kcat and histone phosphorylation efficiency was observed with the Y297F mutant. There was a 3.3-fold reduction in the histone phosphorylation efficiency of the Y317F mutant protein.

Circular Dichroism of STY Protein Kinase Mutants-- The secondary structures of these proteins were monitored by CD. The observed deficiency in enzyme activity for any of these mutant enzymes could have been caused by alterations in the secondary structures of the enzyme. The number of secondary structure elements was calculated from the CD spectra using Antheprot software (29). The CD spectra of the wild-type and mutant STY protein kinases were similar and were characterized by a minimum at 204-205 nm and a shoulder in the 222-225 nm range, suggesting the presence of beta -sheet and alpha -helical structures, respectively. The results from the CD spectral analyses of STY protein kinase and its mutants are given in Table II.


                              
View this table:
[in this window]
[in a new window]
 
Table II
Fraction of secondary elements as calculated from respective CD spectra
Number of secondary structure elements was calculated from the CD spectra using Antheprot software (29).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Regulation of protein kinases is achieved through many different mechanisms, including protein phosphorylation by other kinases (30), autophosphorylation (31), and control by regulatory domains or subunits (32). A key feature of regulation in many protein kinases is thought to be the phosphorylation of one or more residues within the activation loop of the catalytic subunit. STY protein kinase activation by tyrosine phosphorylation within the activation loop is of interest because it suggests possible involvement of STY protein kinase in tyrosine kinase-mediated signaling pathways in plants. Most protein kinases that are activated by phosphorylation of residues in the activation loop belong to arginine/aspartate kinase family (18), in which the aspartate residue in the activation loop has an adjacent arginine. The arginine residue has been hypothesized to form an ionic bridge with the phosphorylated serine or threonine residue that stabilizes the catalytically active conformation (34). STY protein kinase also belongs to the arginine/aspartate kinase family. In this study, we have shown that a conserved tyrosine residue within the activation loop regulates STY protein kinase activity. There is a single tyrosine (Tyr297) in the activation loop of peanut STY protein kinase, and the substitution of Tyr297 with Phe led to a significant loss of catalytic activity in terms of both autophosphorylation and substrate phosphorylation toward histone. Activation of the mammalian dual specificity protein kinases is regulated by the tyrosine phosphorylation of the activation loop. Isoforms of the protein kinase C subfamily can be activated by tyrosine phosphorylation by Bruton's tyrosine kinase or Src family tyrosine kinases (35, 36). Tyrosine phosphorylation of a member of the protein kinase C subfamily is dependent on the activity of a Bruton's tyrosine kinase that may directly phosphorylate the protein kinase C (37). All other kinases that are regulated by tyrosine phosphorylation between subdomains VII and VIII, e.g. MAPK/ERK, JNK, and GSK3, are components of signaling pathways that transduce receptor-initiated signals to nuclear phosphorylation of transcription factors (38). Two requirements have been thought to be critical for the catalytic activity of protein kinases. One is the correct juxtaposition of catalytic groups contributing to the transfer of the gamma -phosphate group from ATP to a serine, threonine, or tyrosine side chain of the substrate (34). The other is the accessibility and correct positioning of the substrate-binding site(s) (30). The mechanism of peanut STY protein kinase activation by phosphorylation could therefore be that phosphorylation promotes a conformation of the activation loop in which the catalytic and substrate-binding sites are correctly formed, resulting in a significant increase in kinase activity. STY protein kinase may also be activated in vivo through activation loop phosphorylation of the tyrosine residue by an upstream kinase(s).

In our studies, mutation of Tyr213 to Phe produced a recombinant enzyme with a 4-fold increase in autophosphorylation and a 2.8-fold increase in substrate phosphorylation activities. A similar observation was made earlier in several protein kinases (32, 39). The catalytic activity of many protein kinases is regulated by an autoinhibitory mechanism known as intrasteric regulation (32). Many protein kinases are maintained in low activity or inactive states through intermolecular or intramolecular association with inhibitory molecules or domains. These inhibitory molecules may be disrupted in response to appropriate stimuli, allowing the protein kinase to adopt an active conformation. Autoinhibitory sequences have been found in protein kinase C, calcium/calmodulin-dependent kinase, myosin light chain kinase, c-Src, the insulin receptor, and twitchin (32, 39, 40). The affinity of autoinhibitory sequences may also be regulated by autophosphorylation or other interactions, but the structural basis for these regulatory mechanisms remains to be elucidated. Casein kinases are also dual specificity kinases, and autophosphorylation has an inhibitory effect on protein kinase activity. Casein kinases are regulated by a C-terminal phosphorylation-dependent autoinhibitory domain (41). Autophosphorylation inactivates the kinase, and mutagenesis of the phosphorylation residues of the C-terminal domain reactivates the kinase. Serine and threonine to alanine mutations that eliminated these autophosphorylation sites in a recombinant casein kinase Iepsilon protein resulted in 8-fold more activity compared with the wild-type enzyme. Further supporting the presence of an inhibitory phosphorylation site in the kinase domain, Kuret and co-workers (42) described two forms of recombinant yeast casein kinase Iepsilon ; one form was autophosphorylated in the kinase domain and had a 4-fold decrease in activity compared with the unphosphorylated protein kinase.

STY protein kinase has homology to the MLKs from mammals. A point mutation (Y52A) in the SH3 domain-binding site of MLK3 abolishes binding to the SH3 domain and increases the MLK3 activity (43). The Y52A mutant shows a 2-fold increase in autophosphorylation and a 2.5-fold increase in histone phosphorylation. SH3 domains are known to bind to proteins containing PXXP sequences that form polyproline type II helices (44). STY protein kinase also has a similar sequence motif in the C-terminal region. Apart from the other examples, substitution of Tyr1162 with Phe in the intact insulin receptor results in an increase in basal protein kinase activity in the absence of insulin, consistent with an autoinhibitory role for Tyr1162 (45). A point mutation in the TEY domain might disrupt the autoinhibitory domain, leading to a conformational change that activates the protein kinase, leading to the increased phosphorylation of all three amino acids. A crystal structure of the STY protein kinase molecule will be required to understand how autophosphorylation of Tyr213 might affect the conformation of STY protein kinase.

STY protein kinase possesses a tyrosine residue within the ATP-binding motif, whereas the vast majority of kinase family members have a phenylalanine at this site (1). The protein kinases with a tyrosine in the ATP-binding domain have been shown to be regulated by tyrosine phosphorylation. Tyr148 in the ATP-binding domain is conserved among STY protein kinase-related sequences. The replacement of Tyr148 with Phe drastically reduced the enzyme activity of peanut STY protein kinase. The tyrosine in the ATP-binding site of cyclin-dependent protein kinases and the phosphorylation of residues in this region are important for the inhibition of kinase activity (16).

Several protein kinases are regulated by tyrosine phosphorylation of the C-terminal region. STY protein kinase has structural similarity to Src tyrosine kinases from chicken and human (46, 47). Src family kinases have a regulatory tyrosine (Tyr527 in p60c-src) toward the C terminus and an autophosphorylation site (Tyr416). Data on the biological properties of p60c-src have shown that mutation of its C-terminal sites of tyrosine phosphorylation can serve to activate or suppress its transforming properties (48-50), indicating that this process is an important regulatory step. The C-terminal region of the epidermal growth factor receptor is important in regulating its biological activity (51). The point mutation of Tyr317 to Phe in the C-terminal region of STY protein kinase resulted in the reduction of autophosphorylation activity.

Our results show that STY protein kinase is a multisite-phosphorylated enzyme and suggest that its phosphorylation may be an intricate process that regulates its biological functions in very distinct ways. Multisite phosphorylation is a characteristic of MAPK-activated protein kinase-2, in which any two of three sites must be phosphorylated to achieve maximal activation (52). Protein kinase D is also phosphorylated at multiple sites such as the activation loop, C-terminal domain, and regulatory domain (33). STY protein kinase is developmentally regulated and is induced by cold and salt stresses (8). The distribution of STY protein kinase autophosphorylation sites in the kinase molecule suggests that different sites may be involved in distinct mechanisms mediated by STY protein kinase during the onset of stress response. Src family kinases and MLKs are dual specificity protein kinases regulated by both autophosphorylation and autoinhibition. Like Src family tyrosine kinases and mammalian MLKs, STY protein kinase has a PXXP sequence motif in the C-terminal region. STY protein kinase might interact through these proline-rich sites with other kinases that are involved in signal transduction. Further studies are needed to identify the upstream kinase(s) that phosphorylate STY protein kinase in its catalytic segment and to fully elucidate the molecular mechanism of the regulation of STY protein kinase activity. These mutants provide an excellent opportunity to dissect in vivo function and regulation of STY protein kinase.

    ACKNOWLEDGEMENTS

We are grateful to the Molecular Biophysics Unit of the Indian Institute of Science for allowing us to use the CD instrument. MALDI mass spectrometry was carried out at the Division of Biological Sciences Protein Core Facility of the Indian Institute of Science. The help of Naveen Rajkumar in the purification of recombinant enzymes is acknowledged. We thank Dr. D. N. Rao for critical reading of the manuscript.

    FOOTNOTES

* This work was supported by a grant from the Council of Scientific and Industrial Research, New Delhi, India.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence to be addressed. Tel.: 91-80-394-2881; Fax: 91-80-360-2627; E-mail: lipid@biochem.iisc.ernet.in.

Published, JBC Papers in Press, March 5, 2003, DOI 10.1074/jbc.M300024200

    ABBREVIATIONS

The abbreviations used are: STY, serine/threonine/tyrosine; MAPK, mitogen-activated protein kinase; TEY, Thr-Glu-Tyr; MEK, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase; MALDI, matrix-assisted laser desorption ionization; ERK, extracellular signal-regulated kinase; JNK, c-Jun N-terminal kinase; GSK, glycogen synthase kinase; MLK, mixed lineage kinase; SH3, Src homology 3.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Hunter, T. (1995) Cell 80, 225-236[Medline] [Order article via Infotrieve]
2. Barizza, E., Schiavo, F. L., Terzi, M., and Filippini, F. (1999) FEBS Lett. 447, 191-194[CrossRef][Medline] [Order article via Infotrieve]
3. Suzuki, K., and Shinshi, H. (1995) Plant Cell 7, 639-647[Abstract/Free Full Text]
4. Kazuhisa, K., Yoshiro, K., Masanori, Y., Nobuyuki, K., Masazumi, S., and Takahide, T. (2000) Nature 407, 37-38[CrossRef][Medline] [Order article via Infotrieve]
5. Ali, N., Halfter, U., and Chua, N.-H. (1994) J. Biol. Chem. 269, 31626-31629[Abstract/Free Full Text]
6. Tregear, J. W., Jouannic, S., Schwebel-Dugue, N., and Kreis, M. (1996) Plant Sci. 117, 107-119[CrossRef]
7. Feng, X.-H., Zhao, Y., Bottino, P. J., and Kung, S.-D. (1993) Biochim. Biophys. Acta 1172, 200-204[Medline] [Order article via Infotrieve]
8. Rudrabhatla, P., and Rajasekharan, R. (2002) Plant Physiol. 130, 380-390[Abstract/Free Full Text]
9. Zhang, S., and Klessig, D. F. (2001) Trends Plant Sci. 6, 520-527[CrossRef][Medline] [Order article via Infotrieve]
10. Shah, K., Vervoort, J., and de Vries, S. C. (2001) J. Biol. Chem. 276, 41263-41269[Abstract/Free Full Text]
11. Sessa, G., Mark, D. A., and Martin, G. B. (2000) EMBO J. 19, 2257-2269[Abstract/Free Full Text]
12. Steinberg, R. A., Clauthron, R. D., Symcox, M. M., and Shuntoh, H. (1993) Mol. Cell. Biol. 13, 2332-2341[Abstract]
13. Payne, D. M., Rossomando, A. J., Martino, P., Erikson, A. K., Her, J. H., Shabanowitz, J., Hunt, D. F., Weber, M. J., and Sturgill, T. W. (1991) EMBO J. 10, 885-892[Abstract]
14. Zheng, C.-F., and Guan, K.-L. (1994) EMBO J. 13, 1123-1131[Abstract]
15. Alessi, D. R., Saito, Y., Campbell, D. G., Cohen, P., Sithanandam, G., Rapp, U., Ashworth, A., Marshall, C. J., and Cowley, S. (1994) EMBO J. 13, 1610-1619[Abstract]
16. Gould, K. L., Moreno, S., Owen, D. J., Sazer, S., and Nurse, P. (1991) EMBO J. 10, 3297-3309[Abstract]
17. Cooper, J. A., and Howell, B. (1993) Cell 73, 1051-1054[Medline] [Order article via Infotrieve]
18. Johnson, L. N., Noble, M. E. M., and Owen, D. J. (1996) Cell 85, 149-158[Medline] [Order article via Infotrieve]
19. Studier, F. W., and Moffatt, B. A. (1986) J. Mol. Biol. 189, 113-130[Medline] [Order article via Infotrieve]
20. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , pp. 25-28, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
21. Wilkins, M. R., Lindskog, I., Gasteiger, E., Bairoch, A., Sanchez, J. C., Hochstrasser, D. F., and Appel, R. D. (1997) Electrophoresis 18, 403-408[Medline] [Order article via Infotrieve]
22. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve]
23. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
24. Munoz, G., and Marshall, S. H. (1990) Anal. Biochem. 190, 233-237[Medline] [Order article via Infotrieve]
25. Becker, W., Weber, Y., Wetzel, K., Eirmbter, K., Tejedor, F. J., and Joost, H. G. (1998) J. Biol. Chem. 273, 25893-25902[Abstract/Free Full Text]
26. Guex, N., and Peitsch, M. C. (1997) Electrophoresis 18, 2714-2723[Medline] [Order article via Infotrieve]
27. Sayle, R., and Milner-White, E. J. (1995) Trends Biochem. Sci. 20, 374[CrossRef][Medline] [Order article via Infotrieve]
28. Morgan, D. O., and De Bondt, H. L. (1994) Curr. Opin. Cell Biol. 6, 239-246[Medline] [Order article via Infotrieve]
29. Deleage, G., and Geourjon, C. (1993) Comput. Appl. Biosci. 9, 197-199[Abstract]
30. Elion, E. A. (1998) Science 281, 1625-1626[Free Full Text]
31. Cooper, J. A., and MacAuley, A. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 4232-4236[Abstract]
32. Soderling, T. R. (1990) J. Biol. Chem. 265, 1823-1826[Free Full Text]
33. Vertommen, D., Rider, M., Ni, Y., Waelkens, E., Merlevede, W., Vandenheede, J. R., and Van Lint, J. (2000) J. Biol. Chem. 275, 19567-19576[Abstract/Free Full Text]
34. Dajani, R., Fraser, E., Roe, S. M., Yong, N., Good, V., Dale, T. C., and Pearl, L. H. (2001) Cell 105, 721-732[CrossRef][Medline] [Order article via Infotrieve]
35. Kawakami, Y., Kitaura, J., Hartman, S. E., Lowell, C. A., Siraganian, R. P., and Kawakami, T. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 7423-7428[Abstract/Free Full Text]
36. Liu, Y., Witte, S., Liu, Y.-C., Doyle, M., Elly, C., and Altman, A. (2000) J. Biol. Chem. 275, 3603-3609[Abstract/Free Full Text]
37. Crosby, D., and Poole, A. W. (2002) J. Biol. Chem. 277, 9958-9965[Abstract/Free Full Text]
38. Hill, C. S., and Treisman, R. (1995) Cell 200, 199-211
39. Lei, J., Tang, X., Chambers, T. C., Pohl, J., and Benian, G. M. (1994) J. Biol. Chem. 269, 21078-21085[Abstract/Free Full Text]
40. Heierhorst, J., Probst, W. C., Vilim, F. S., Buku, A., and Weiss, K. R. (1994) J. Biol. Chem. 269, 21086-21093[Abstract/Free Full Text]
41. Gietzen, K. F., and Virshup, D. M. (1999) J. Biol. Chem. 274, 32063-32070[Abstract/Free Full Text]
42. Carmel, G., Leichus, B., Cheng, X., Patterson, S. D., Mirza, U., Chait, B. T., and Kuret, J. (1994) J. Biol. Chem. 269, 7304-7309[Abstract/Free Full Text]
43. Zhang, H., and Gallo, A. K. (2001) J. Biol. Chem. 276, 45598-45603[Abstract/Free Full Text]
44. Feng, S., Chen, J. K., Yu, H., Simon, J. A., and Schreiber, S. L. (1994) Science 266, 1241-1247[Medline] [Order article via Infotrieve]
45. Hubbard, S. R., Mohammadi, M., and Schlessinger, J. (1998) J. Biol. Chem. 273, 11987-11990[Free Full Text]
46. Weijland, A., Williams, J. C., Neubauer, G., Courtneidge, S. A., Wierenga, R. K., and Superti-Furga, G. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 3590-3595[Abstract/Free Full Text]
47. Xu, W., Doshi, A., Lei, M., Eck, M. J., and Harrison, S. C. (1999) Mol. Cell 3, 629-638[Medline] [Order article via Infotrieve]
48. Kmiecik, T. E., and Shalloway, D. (1987) Cell 49, 65-73[Medline] [Order article via Infotrieve]
49. Piwnica-Worms, H., Saunders, K. B., Roberts, T. M., Smith, A. E., and Cheng, S. H. (1987) Cell 49, 75-82[Medline] [Order article via Infotrieve]
50. Cartwright, C. A., Eckhart, W., Simon, S., and Kaplan, P. L. (1987) Cell 49, 83-91[Medline] [Order article via Infotrieve]
51. Riedel, H., Schlessinger, J., and Ullrich, A. (1987) Science 236, 197-200[Medline] [Order article via Infotrieve]
52. Ben-Levy, R., Leighton, I. A., Doza, Y. N. D., Attwood, P., Morrice, N., Marshall, C., and Cohen, P. (1995) EMBO J. 14, 5920-5930[Abstract]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.



This Article
Abstract
Full Text (PDF)
All Versions of this Article:
278/19/17328    most recent
M300024200v1
Purchase Article
View Shopping Cart
Alert me when this article is cited
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Copyright Permissions
Google Scholar
Articles by Rudrabhatla, P.
Articles by Rajasekharan, R.
Articles citing this Article
PubMed
PubMed Citation
Articles by Rudrabhatla, P.
Articles by Rajasekharan, R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   Biochemistry and Molecular Biology Education 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.